Bruxism
Conditions
Interventions
This is a controlled blind randomized clinical trial. Randomization will be performed before the procedures using an internet-based computer program (http://www.randomization.com/) in blocks of 4 pati
Sponsors
Faculdade de Odontologia da Universidade do Estado do Rio de Janeiro
Faculdade de Odontologia da Universidade do Estado do Rio de Janeiro
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Volunteers of both genders; aged between 18 and 60 years; with Temporomandiibular Disorders; With high frequency of awake bruxism activity
Exclusion criteria
Exclusion criteria: Volunteers with facial and Temporomanbular Joint trauma; using full dentures or removable partial dentures; ongoing orthodontic treatment; blood dyscrasia patients; with presence of arthritis; arthrosis; diabetes; neurological pathologies; fibromyalgia; who received tetanus vaccine or botulinum toxin injections in the three months prior to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Frequency of Awake Bruxism activity reduction in a period of six months, verified through ecological momentary assessment (BruxApp®) and the Oral Behavior Checklist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: Pain reduction in a period of six months, verified through the methods of Visual Analog Scale (VAS), from the evidence of a decrease of at least 2 points in VAS.;Expected outcome 3: Decrease in psychosocial impairment in six-month period, verified through anxiety, depression and stress questionnaires; with an evidence of a decrease of at least 5% in pre and post-intervention measurements. | — |
Countries
Brazil
Contacts
Public ContactTatiana Foscaldo
Faculdade de Odontologia da Universidade do Estado do Rio de Janeiro
Outcome results
None listed